Literature DB >> 18373429

Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.

Julia Y Ljubimova1, Manabu Fujita, Alexander V Ljubimov, Vladimir P Torchilin, Keith L Black, Eggehard Holler.   

Abstract

Nanoconjugates are emerging as promising drug-delivery vehicles because of their multimodular structure enabling them to actively target discrete cells, pass through biological barriers and simultaneously carry multiple drugs of various chemical nature. Nanoconjugates have matured from simple devices to multifunctional, biodegradable, nontoxic and nonimmunogenic constructs, capable of delivering synergistically functioning drugs in vivo. This review mainly concerns the Polycefin family of natural-derived polymeric drug-delivery devices as an example. This type of vehicle is built by hierarchic conjugation of functional groups onto the backbone of poly(malic acid), an aliphatic polyester obtained from the microorganism Physarum polycephalum. Particular Polycefin variants target human brain and breast tumors implanted into animals specifically and actively and could be detected easily by noninvasive imaging analysis. Delivery of antisense oligonucleotides to a tumor-specific angiogenic marker using Polycefin resulted in significant inhibition of tumor angiogenesis and increase of animal survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373429      PMCID: PMC2734385          DOI: 10.2217/17435889.3.2.247

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  107 in total

1.  Vector-mediated drug delivery to the brain.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.

Authors:  Mary Jo Turk; Joseph A Reddy; Jean A Chmielewski; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2002-02-10

Review 3.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

Authors:  Thomas Merdan; Jindrich Kopecek; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

4.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

Review 5.  The role of the thrombospondins in healing myocardial infarcts.

Authors:  Khaled Chatila; Guofeng Ren; Ying Xia; Peter Huebener; Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

6.  Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Authors:  Sandrine Faivre; Catherine Delbaldo; Karina Vera; Caroline Robert; Stéphanie Lozahic; Nathalie Lassau; Carlo Bello; Samuel Deprimo; Nicoletta Brega; Giorgio Massimini; Jean-Pierre Armand; Paul Scigalla; Eric Raymond
Journal:  J Clin Oncol       Date:  2005-11-28       Impact factor: 44.544

7.  Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins.

Authors:  Enrico Mastrobattista; Gerben A Koning; Louis van Bloois; Ana C S Filipe; Wim Jiskoot; Gert Storm
Journal:  J Biol Chem       Date:  2002-05-20       Impact factor: 5.157

Review 8.  Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review.

Authors:  A L Takeda; J Colquitt; A J Clegg; J Jones
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

Review 9.  Reversible covalent chemistry in drug delivery.

Authors:  Kevin R West; Sijbren Otto
Journal:  Curr Drug Discov Technol       Date:  2005-09

Review 10.  Cancer-targeted polymeric drugs.

Authors:  Y Luo; G D Prestwich
Journal:  Curr Cancer Drug Targets       Date:  2002-09       Impact factor: 3.428

View more
  16 in total

1.  Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].

Authors:  Hui Ding; Satoshi Inoue; Alexander V Ljubimov; Rameshwar Patil; Jose Portilla-Arias; Jinwei Hu; Bindu Konda; Kolja A Wawrowsky; Manabu Fujita; Natalya Karabalin; Takako Sasaki; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.

Authors:  Hui Ding; Jose Portilla-Arias; Rameshwar Patil; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Biomaterials       Date:  2011-04-22       Impact factor: 12.479

3.  Nanomaterials in controlled drug release.

Authors:  Xin-Jun Cai; Ying-Ying Xu
Journal:  Cytotechnology       Date:  2011-07-01       Impact factor: 2.058

4.  Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.

Authors:  Rameshwar Patil; Pallavi R Gangalum; Shawn Wagner; Jose Portilla-Arias; Hui Ding; Arthur Rekechenetskiy; Bindu Konda; Satoshi Inoue; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Macromol Biosci       Date:  2015-06-02       Impact factor: 4.979

5.  Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).

Authors:  Rameshwar Patil; José Portilla-Arias; Hui Ding; Satoshi Inoue; Bindu Konda; Jinwei Hu; Kolja A Wawrowsky; Paul K Shin; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

6.  Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery.

Authors:  José Portilla-Arias; Rameshwar Patil; Jinwei Hu; Hui Ding; Keith L Black; Montserrat García-Alvarez; Sebastián Muñoz-Guerra; Julia Y Ljubimova; Eggehard Holler
Journal:  J Nanotechnol       Date:  2010

Review 7.  Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

Authors:  Liron L Israel; Anna Galstyan; Eggehard Holler; Julia Y Ljubimova
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

8.  Polymeric conjugates for drug delivery.

Authors:  Nate Larson; Hamidreza Ghandehari
Journal:  Chem Mater       Date:  2012-01-04       Impact factor: 9.811

Review 9.  Covalent nano delivery systems for selective imaging and treatment of brain tumors.

Authors:  Julia Y Ljubimova; Tao Sun; Leila Mashouf; Alexander V Ljubimov; Liron L Israel; Vladimir A Ljubimov; Vida Falahatian; Eggehard Holler
Journal:  Adv Drug Deliv Rev       Date:  2017-06-10       Impact factor: 15.470

10.  Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.

Authors:  Jose Portilla-Arias; Rameshwar Patil; Hui Ding; Julia Y Ljubimova; Satoshi Inoue; Janet L Markman; Arthur Rekechenetskiy; Bindu Konda; Pallavi R Gangalum; Alexandra Chesnokova; Alexander V Ljubimov; Keith L Black; Eggehard Holler
Journal:  J Drug Target       Date:  2013-09-16       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.